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Abstract
Hepcidin, a 25-amino acid peptide hormone, is the principal regulator of plasma iron concentrations. Hepcidin binding to its
receptor, the iron exporter ferroportin, induces ferroportin internalization and degradation, thus blocking iron efflux from
cells into plasma. The aim of this study was to characterize the fate of hepcidin after binding to ferroportin. We show that
hepcidin is taken up by ferroportin-expressing cells in a temperature- and pH-dependent manner, and degraded together
with its receptor. When Texas red-labeled hepcidin (TR-Hep) was added to ferroportin-GFP (Fpn-GFP) expressing cells,
confocal microscopy showed co-localization of TR-Hep with Fpn-GFP. Using flow cytometry, we showed that the peptide
was almost completely degraded by 24 h after its addition, but that lysosomal inhibitors completely prevented degradation
of both ferroportin and hepcidin. In addition, using radio-labeled hepcidin and HPLC analysis we show that hepcidin is not
recycled, and that only degradation products are released from the cells. Together these results show that the hormone
hepcidin and its receptor ferroportin are internalized together and trafficked to lysosomes where both are degraded.
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Introduction
The interaction between the iron-regulatory hormone hepcidin
and its receptor, the cellular iron exporter ferroportin, is central to
mammalian iron homeostasis. Hepcidin is a 25 amino acid hepatic
peptide hormone that controls the delivery of iron to blood plasma
so as to meet cellular iron needs but avoid iron excess and toxicity.
Hepcidin acts by binding to ferroportin on cell surfaces, inducing
ferroportin internalization and degradation, and thereby blocking
iron efflux into plasma from professional iron-exporting cells:
hepatocytes, duodenal enterocytes, splenic and other macrophages
and syncytiotrophoblasts [1,2]. Dysregulated or defective produc-
tion of hepcidin and ferroportin, or a defect in their interaction,
results in various iron disorders.
Many peptide hormones, including insulin, parathyroid hor-
mone and substance P, induce receptor endocytosis. Endocytosed
receptors may be degraded or recycled but their ligands may
dissociate during endocytosis and thus may or may not follow the
fate of their receptor [3]. Previous studies have shown that binding
of hepcidin to ferroportin results in ubiquitination of the receptor
which leads to its internalization and subsequent degradation in
lysosomes [1,4–6]. Although the pathways of ferroportin internal-
ization and degradation have been partially characterized, the
molecular mechanisms governing the intracellular fate of hepcidin
have not yet been investigated. Here we examine the formation of
the hepcidin-ferroportin receptor-ligand complex and follow the
cellular fate of the receptor-bound hepcidin.
Materials and Methods
Cell line
ECR293-Fpn, a stable cell line expressing Fpn-GFP under the
control of ponasterone-inducible promoter was described previ-
ously [1].
Fluorescent hepcidin preparation
Texas-red hepcidin (TR-Hep) preparation was previously
described [7]. Briefly, synthetic hepcidin (Peptides International,
Louisville, KY) was incubated with Texas Red-X succinimidyl
ester (Molecular Probes, Eugene, OR) in PBS with sodium
bicarbonate for 1 hr at RT. Labeled hepcidin was purified on a
C18 Sep-Pak cartridge (Waters, Milford, MA), followed by the
purification by RP-HPLC on a Vydac C18 column (Waters).
Purified TR hepcidin was resuspended in DMSO and stored
protected from light. Each time a working solution of TR-Hep was
prepared, the solution was vigorously resuspended and sonicated
to disrupt peptide aggregates.
Confocal microscopy analysis
ECR-Fpn cells were plated in a 12-well plate on 12 mm poly-D-
lysine coated round coverslips (Becton Dickinson, Franklin Lakes,
NJ) in the presence of 20 mM ferric ammonium citrate (FAC) with
or without 10 mM ponasterone. FAC is added to the medium to
prevent cellular iron depletion caused by prolonged Fpn-GFP
overexpression. After 24 h, ponasterone was washed off, and cells
were treated with 1 mg/ml TR-Hep at 37uC protected from light.
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After 1 hour, cells were washed with PBS two times and the
coverslip was placed on a slide, sealed with clear nail polish and
immediately analyzed. Images were scanned at the UCLA CNSI
Advanced Light Microscopy Facility and the BRI Cell Imaging
Facility on a Leica TCS-SP MP Confocal and Multiphoton
Inverted Microscope (Heidelberg, Germany) equipped with an
argon laser (488 nm blue excitation: JDS Uniphase), a 561 nm
(green) diode laser (DPSS: Melles Griot), and a two photon laser
setup consisting of a Spectra-Physics Millenia6532 nm green
diode pump laser and a Tsunami Ti-Sapphire picosecond pulsed
infrared laser tuned at 768 nm for UV excitation. Images were
acquired using LCS Lite software (Leica Confocal Software, Leica
Microsystems, Manheim, Germany).
Flow cytometry analysis
ECR-Fpn cells were plated on poly-D-lysine-coated plates in the
presence of 20 mM FAC, with or without 10 mM ponasterone.
After 24 h, ponasterone was washed off, and cells were loaded
with 1 mg/ml TR-Hep for 4 h. After 4 h, cells were washed with
PBS, fresh media was added and cells were treated with or without
lysosomal inhibitors chloroquine (100 mM) and bafilomycin
(100 nM). Twenty hours after the addition of inhibitors, cells
were trypsinized and resuspended at 16106 cells/ml, and the
intensity of red and green fluorescence was analyzed by flow
cytometry at UCLA Jonsson Comprehensive Cancer Center and
Center for AIDS Research Flow Cytometry Core Facility
(supported by NIH awards CA-16 042 and AI-28 697, the UCLA
AIDS institute, and the UCLA School of Medicine). Flow
cytometry was performed on FACSVantage SE sorting flow
cytometer with digital electronics (Becton Dickinson, San Jose,
CA) and analyzed with FACSDiva software (Becton Dickinson).
Cells not induced with ponasterone were used to establish a gate to
exclude background fluorescence. Loss of cellular Fpn-GFP was
quantified as % of green fluorescence in induced cells not treated
with hepcidin. Degradation of cellular TR-Hep was measured as
% of red fluorescence in induced cells treated with TR-Hep for
4 h.
Hepcidin radioiodination
For cellular studies, synthetic hepcidin with M21Y substitution
was iodinated with 125I as previously described [1].
Temperature and pH dependent 125I-hepcidin
internalization assay
125I-hepcidin (106 cpm, specific activity ,107 cpm/mg) was
added to ECR-Fpn cells plated on poly-D-lysine coated plates in
the presence of 20 mM FAC, with or without 10 mM ponasterone.
Cells were incubated with radiolabeled hepcidin at different
temperatures (0, 15, 23 and 37uC) for 1 hour. For pH
experiments, growth medium was replaced with media adjusted
to pH of 2, 4, 5, 6, 7, 8 and 9 (without additional FAC) and
radiolabeled hepcidin was added for 1 h at 37uC. Cells were
washed with phosphate-buffered saline (PBS) to remove unbound
radioactive hepcidin and centrifuged for 2 minutes at 12,000xg
through a silicone oil layer (Nyosil M25; Nye). The radioactivity in
cell pellets was determined by gamma counting. The temperature-
dependence data are expressed in counts-per-minute (cpm),
whereas pH-dependence data were normalized because of the
variability in absolute cpm values between experiments and
expressed as % of radioactivity at pH 7. The radioactivity of
uninduced cells subtracted as background for each point.
Hepcidin recycling
ECR-Fpn cells were plated on poly-D-lysine coated plates in the
presence of 20 mM FAC, with or without 10 mM ponasterone, and
incubated at 37uC. After 24 h, cells were washed with PBS and
1 ml of serum free media was added. The cells were treated with
56105 cpm of 125I–hepcidin for 2 h (loading period) at 37uC.
After 2 h the cells were washed 3 times with DMEM/10% fetal
bovine serum to remove unbound 125I-hepcidin and 1 ml serum-
free media with 20 mM FAC was added to all wells. Cells were
incubated at 37uC for 5 min, 4, 8 and 24 h after loading. To
prevent lysosomal acidification and proteolysis, 100 nM bafilo-
mycin was added to assigned wells for 24 h. The supernatant was
collected, its radioactivity quantified by a gamma counter, and an
aliquot subjected to HPLC analysis. The cells were washed once
and centrifuged for 2 min at 12,000xg through a silicone oil layer
(Nyosil M25, Nye, Fairhaven, MA). The radioactivity in cell pellets
was determined by gamma counting (Beckman, Fullerton, CA).
HPLC analysis of cell media
Aliquots of the supernatants were analyzed by reversed-phase
high-performance liquid chromatography (RP-HPLC) on Vydac
C18 column (218TP54; Waters). Fractions were eluted over 30
minutes with an acetonitrile gradient (1 fraction per minute) and
their radioactivity determined by gamma counting.
Statistical analysis
SigmaStat 11 was used for statistical analyses (Systat Software,
Point Richmond, CA), and groups were compared using t-test.
Results
Effect of temperature and pH on binding/internalization
of 125I-hepcidin and Fpn
The binding of 125I-hepcidin to Fpn-GFP expressing cells was
temperature- and pH-dependent. Binding decreased with temper-
atures below 37uC (Figure 1a), confirming our previous observa-
tions at 0uC [1]. At 0uC and 15uC, binding was similar in cells
expressing or not expressing ferroportin. This temperature
dependence may be due to hepcidin insertion into cell membrane
during the binding step.
Hepcidin binding to ferroportin was also pH dependent, with
50% binding seen at pH 6 and highest binding at pH 9 (Figure 1b).
As disulfide exchange is promoted at alkaline pH, this observation
is consistent with our previous work showing thiol-disulfide
interaction between hepcidin and ferroportin [7,8]. Hepcidin did
not bind specifically at pH lower than 6.
Hepcidin is co-internalized with ferroportin
To assess the fate of hepcidin after cell surface binding, we
added TR-Hep to Fpn-GFP expressing cells for 1 h and using
confocal microscopy detected nearly complete co-localization of
red hepcidin with green ferroportin in vesicles (Figure 2),
indicating that after binding, hepcidin internalizes together with
ferroportin.
Hepcidin is degraded together with ferroportin in
lysosomes
We previously showed that upon binding of hepcidin,
ferroportin is internalized and degraded in lysosomes [1]. Here
we used flow cytometry to show that 24 h after addition of TR-
Hep to cells, not only Fpn-GFP but also TR-Hep is nearly
completely degraded (Figure 3). Addition of lysosomal inhibitors
Catabolism of Hepcidin
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chloroquine and bafilomycin completely prevented the degrada-
tion of both hepcidin and ferroportin.
Hepcidin is not recycled
In order to determine whether hepcidin is recycled, we added
radiolabeled hepcidin for 2 h to cells expressing Fpn-GFP, washed
the unbound ligand and monitored the integrity of the radiola-
beled species released into the media by HPLC over 24 h. In cells
expressing Fpn-GFP, radiolabeled hepcidin was internalized by
the cells and the cellular radioactivity was lost over 24 h
(Figure 4a). The addition of bafilomycin, an inhibitor of lysosomal
acidification and proteolysis, increased the retention of radioac-
tivity in cells, confirming that hepcidin is degraded in lysosomes.
Analysis of the supernatants showed that radioactivity was released
from cells over 24 h (Figure 4b). To characterize the radioactive
species released into the media we analyzed an aliquot of the
supernatant by HPLC. In cells not expressing ferroportin, the
radioactive species was recovered in a single peak (fractions #21–
24) and with low counts (Figure 4c), suggesting that the
radioactivity could be attributed to hepcidin that was weakly
bound to cell surface and released into the media. In cells
expressing Fpn-GFP, the radioactive species recovered from
supernatants after 5 minutes also eluted as a single peak in
fractions equivalent to those from cells not expressing Fpn
(fractions #21–24), suggesting that this species is intact hepcidin.
After 4 h, two prominent peaks appeared (fractions # 13–15 and
27–30) and we speculate that these radioiodinated forms could
correspond to the two known degradation products of hepcidin-25
detected in urine [9], which are truncated at the N-terminus by 3
or 5 amino acids (hepcidin-22 and hepcidin-20 respectively). The
naturally occurring urinary forms eluted from our HPLC system
after and before hepcidin-25, respectively [9] and are both much
less active than hepcidin-25 [10]. The rest of the molecule is
extensively crosslinked by disulfide bonds and would be expected
to be more resistant to proteolysis. In supernatants collected after
8 h and 24 h most of the radioactivity eluted in earlier fractions
(#10–15), indicative of more extensively degraded forms of
hepcidin (Figure 4d).
Figure 1. Effect of temperature and pH on the uptake of 125I-hepcidin by cells expressing Fpn-GFP. ECR293cells were either not induced
(-pon) or induced with ponasterone (+pon) to express Fpn-GFP. (A) Cells were incubated with 125I-hepcidin for 1 h at 0uC, 15uC, 23uC and 37uC, and
the amount of radioactivity bound to cells was measured by gamma counting. *p,0.001, **p = 0.024 compared to uninduced cells at the same
temperature. (B) Cells were incubated with 125I-hepcidin for 1 h at pH 2, 4, 5, 6, 7, 8 and 9, and the amount of radioactivity bound to cells was
measured by gamma counter. Radioactivity in uninduced cells was subtracted as background. Because of the variation in absolute counts between
separate experiments, data within each experiment were normalized to 125I-hepcidin uptake at pH 7. *p,0.01. All experiments were repeated a
minimum of three times, and the error bars represent the standard deviation.
doi:10.1371/journal.pone.0058934.g001
Figure 2. Hepcidin is co-internalized together with ferroportin.
TR labeled hepcidin was added to cells expressing Fpn-GFP, and
incubated at 37uC for 1 h protected from light. Cells were imaged by
fluorescence confocal microscopy. Uninduced cells treated with TR
hepcidin had no detectable red fluorescence (data not shown).
doi:10.1371/journal.pone.0058934.g002
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Discussion
Our study provides insight into the molecular interactions of
hepcidin and ferroportin and establishes the fate of hepcidin after
binding to its receptor. Hepcidin binding to ferroportin is
temperature-dependent, with no binding seen at 0uC as described
before [1], and a progressive increase in binding only at
temperatures above 15uC. The temperature-dependent changes
in binding are probably not due to conformational changes in
hepcidin as the hepcidin conformer populations do not alter
sufficiently between 15uC and 37uC to explain differences in
biological activity [11]. However, other mechanisms could be
involved. Temperature-dependent phase transitions in membrane
lipids have been shown to affect transport functions, enzyme
activity, and hormone-receptor interactions [12,13]. Ferroportin
was reported to be associated with lipid rafts and alterations of the
lipid environment affected hepcidin-induced endocytosis and
degradation of ferroportin in macrophages [14]. Moreover,
hepcidin is similar to antimicrobial peptides defensins, as shown
by its cationic charge, cysteine bridges, and amphipathic structure
[11,15,16]. Defensins act by embedding in the membrane and
increasing membrane permeability [17]. Like defensins, hepcidin
has antimicrobial activity, though high concentrations are
required for this effect. Given its structural resemblance to
defensins, hepcidin may interact with the cell membrane in a
temperature-dependent manner, and this interaction could
modulate its binding to ferroportin.
Hepcidin binding to Fpn is pH dependent with no binding seen
at pHs lower than 6, and the greatest binding at pHs higher than
physiological pH (8 and 9). We have previously shown that residue
C326 of Fpn is critical for hepcidin binding and that thiols are
required for the Fpn-hepcidin interaction, suggesting the possibil-
ity of a disulfide bond exchange between one of the four hepcidin
disulfide bridges and C326-SH on Fpn [7,8]. The thiolate anion is
the reactive species in a disulfide exchange reaction, so the rate of
the reaction is greatest at alkaline pH values [18]. Therefore,
higher pH may promote disulfide bond exchange between
hepcidin and ferroportin and facilitate stable binding. Other
potentially important effects of pH on hepcidin include the effects
on histidine in position 3 (H3), an amino acid important for
binding to ferroportin [19]. At lower pH, the cationized histidine
side chain may decrease ligand-receptor affinity [20].Indeed,
substitution of cationic lysine for H3 or several other residues in
this region of hepcidin largely ablated hepcidin bioactivity [21].
In this study we show using confocal microscopy that hepcidin
and ferroportin co-localize after binding and internalization, and
that both are degraded. Addition of the lysosomal inhibitors
chloroquine and bafilomycin completely prevented degradation of
both molecules, showing that the lysosomes are the main site of
endocytic proteolysis for both molecules, and extending on
previous reports that the lysosome is the main destination for
endocytosed ferroportin [1,5,6].
To rule out the possibility that a substantial amount of hepcidin
may be recycled, we analyzed radiolabeled hepcidin in the cells
expressing Fpn-GFP or not, and their respective supernatants.
After a loading period of cells with 125I-hepcidin for 2 h, we
monitored the integrity of the radioactive species released into the
media. There was an almost complete loss of radioactivity from
cell pellets after 8 h which correlated with the appearance of
radioactive species in the media. HPLC analysis of the supernatant
revealed that radioactivity was associated with fractions that eluted
at different times than intact 125I-hepcidin, indicating that
hepcidin is not significantly recycled. In this experiment, addition
of bafilomycin, a lysosomal acidification and proteolysis inhibitor,
Figure 3. Hepcidin is degraded together with ferroportin. ECR293cells were either not induced (-pon, dashed lines) or were induced with
ponasterone to express Fpn-GFP (+pon, solid lines). Cells were treated with Texas Red-labeled hepcidin (TR-hepc) for 4 h, the peptide was then
removed, and cells were incubated for another 20 h in the absence or presence of lysosomal inhibitors chloroquine (100 mM, green lines) or
bafilomycin (100 nM, blue lines). Cells treated with hepcidin but not inhibitors are represented as black lines (no inh). The amount of cellular Fpn-GFP
or Texas Red-hepcidin was determined by flow cytometry. Uninduced cells were used to establish a gate to exclude background fluorescence. (A)
Quantitation of Fpn-GFP. Data are expressed relative to the green fluorescence of induced cells not treated with hepcidin. (B) Quantitation of Texas
Red-hepcidin. Data are expressed relative to the red fluorescence of induced cells treated with Texas Red-hepcidin for 4 h.
doi:10.1371/journal.pone.0058934.g003
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also caused accumulation of radioactivity in cell pellets, confirming
that hepcidin is degraded in lysosomes.
This study was the first to examine the fate of hepcidin from its
initial binding to ferroportin to its cellular catabolism. We show
here that hepcidin is internalized together with ferroportin and
that both are degraded in lysosomes. Because of the small size of
hepcidin (,2.7 kD) and its weak binding to plasma proteins [22],
glomerular filtration and proteolysis in proximal tubules [23] is
thought to be the major mechanism for hepcidin clearance from
blood. Detectable concentrations of hepcidin in urine, indicative of
peptide that escaped proteolysis in the proximal tubules, are
consistent with this mechanism [24], as is the efficient clearance of
hepcidin into the dialysate during hemodialysis [25]. The extent to
which ferroportin-mediated endocytosis and proteolysis of hepci-
din contributes to its clearance under normal or pathological
conditions remains to be examined.
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